282 related articles for article (PubMed ID: 10657902)
21. Staurosporine resistance accompanies DNA tumor virus-induced immortalization and is independent of the expression and activities of ERK1, ERK2, cyclin A, cyclin-dependent kinase (cdk) 2, and cdk4.
Chang T; Khalsa O; Wang H; Lee ME; Schlegel R
Cell Growth Differ; 1996 Mar; 7(3):361-72. PubMed ID: 8838866
[TBL] [Abstract][Full Text] [Related]
22. HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes.
Boccardo E; Noya F; Broker TR; Chow LT; Villa LL
Virology; 2004 Oct; 328(2):233-43. PubMed ID: 15464843
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
24. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
26. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
Lathion S; Schaper J; Beard P; Raj K
Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
28. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells.
Hu G; Liu W; Mendelsohn J; Ellis LM; Radinsky R; Andreeff M; Deisseroth AB
J Natl Cancer Inst; 1997 Sep; 89(17):1271-6. PubMed ID: 9293917
[TBL] [Abstract][Full Text] [Related]
29. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
Toussaint-Smith E; Donner DB; Roman A
Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
[TBL] [Abstract][Full Text] [Related]
30. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
31. Growth arrest of HPV-positive cells after histone deacetylase inhibition is independent of E6/E7 oncogene expression.
Finzer P; Ventz R; Kuntzen C; Seibert N; Soto U; Rösl F
Virology; 2002 Dec; 304(2):265-73. PubMed ID: 12504567
[TBL] [Abstract][Full Text] [Related]
32. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity.
Gu Z; Matlashewski G
J Virol; 1995 Dec; 69(12):8051-6. PubMed ID: 7494320
[TBL] [Abstract][Full Text] [Related]
33. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.
Stöppler H; Stöppler MC; Johnson E; Simbulan-Rosenthal CM; Smulson ME; Iyer S; Rosenthal DS; Schlegel R
Oncogene; 1998 Sep; 17(10):1207-14. PubMed ID: 9771963
[TBL] [Abstract][Full Text] [Related]
34. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
35. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
36. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
Liu X; Han S; Baluda MA; Park NH
Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
[TBL] [Abstract][Full Text] [Related]
38. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation.
Xiong Y; Kuppuswamy D; Li Y; Livanos EM; Hixon M; White A; Beach D; Tlsty TD
J Virol; 1996 Feb; 70(2):999-1008. PubMed ID: 8551641
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
[TBL] [Abstract][Full Text] [Related]
40. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q.
Steenbergen RD; Walboomers JM; Meijer CJ; van der Raaij-Helmer EM; Parker JN; Chow LT; Broker TR; Snijders PJ
Oncogene; 1996 Sep; 13(6):1249-57. PubMed ID: 8808699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
